Indications
Asthma Mometasone Furoate is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. It is not indicated for the relief of acute bronchospasm. It is not indicated in children less than 4 years of age.
Dosage And Administration
Recommended Dosages in Patients 4 Years of Age and Older.Previous Therapy: Patients ≥ 12 years who received bronchodilators alone
Recommended Starting Dose: 220 µg once daily in the evening
Highest Recommended Daily: 220 µg twice daily or as 440 µg once daily
Previous Therapy: Patients ≥ 12 years who received inhaled corticosteroids
Recommended Starting Dose: 220 µg once daily
Highest Recommended Daily: 440 µg once daily or 440 µg twice daily.
Previous Therapy: Patients ≥ 12 years who received oral corticosteroids
Recommended Starting Dose: 4400 µg once daily
Highest Recommended Daily: 440 µg once daily or 440 µg twice daily.
Side Effects
Generally side effects are mild like headache, viral infection, sore throat, nosebleeds and coughing. Systemic and local corticosteroid use may result few side effects like candida infection, immunosuppression, hypercorticism, adrenal suppression, growth effects, glaucoma and cataracts.
Precautions And Warnings
Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole etc.
Pregnancy And Lactation
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Mometasone Furoate, like other corticosteroids should be used during pregnancy only if the potential benefits justify the potential risk to the fetus.Lactation: It is not known if Mometasone Furoate is excreted in human milk. Since other corticosteroids are excreted in human milk, caution should be used when Mometasone Furoate is administered to nursing women.